Literature DB >> 12918898

Phaeochromocytoma presenting as dilated cardiomyopathy.

M N Attar1, P K Moulik, G D Salem, E L Rose, A A Khaleeli.   

Abstract

Phaeochromocytomas are rare endocrine tumours that secrete excessive amounts of catecholamines and can lead to myocarditis and cardiomyopathy. We report a 63-year-old man with long-standing hypertension and diabetes who presented with dilated cardiomyopathy, which was initially thought to be secondary to ischaemic heart disease. Subsequent coronary angiography was normal. Carvedilol therapy unmasked the characteristic features of phaeochromocytoma. Surgical resection of a right adrenal tumour cured his symptoms, hypertension and diabetes, as well as causing a substantial improvement in cardiac function. Phaeochromocytoma should be considered as a rare cause of dilated cardiomyopathy of uncertain aetiology.

Entities:  

Mesh:

Year:  2003        PMID: 12918898

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

1.  Severe reversible dilated cardiomyopathy in a patient with multiple endocrine neoplasia 2A syndrome.

Authors:  A Gursoy; M F Erdogan; N Kamel
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

2.  Isolated junctional tachycardia in a patient with pheochromocytoma: an unusual presentation of an uncommon disease.

Authors:  Jeffrey J Kim; Santiago O Valdes; Naomi J Kertesz; Bryan C Cannon
Journal:  Pediatr Cardiol       Date:  2007-11-08       Impact factor: 1.655

3.  Recurrent catecholamine-induced cardiomyopathy in a patient with a pheochromocytoma.

Authors:  Se Yong Jang; Dong Heon Yang; Sang Hyuk Lee; Jae Hee Kim; Sun Hee Park; Hun Sik Park; Yongkeun Cho; Shung Chull Chae; Jae Eun Jun; Wee Hyun Park
Journal:  Korean Circ J       Date:  2009-06-30       Impact factor: 3.243

Review 4.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease?

Authors:  Jenn Rachelle U Santos; Alessandra Brofferio; Bruna Viana; Karel Pacak
Journal:  Horm Metab Res       Date:  2018-09-18       Impact factor: 2.936

6.  Composite pheochromocytoma-ganglioneuroma of the adrenal gland: A case report with immunohistochemical study.

Authors:  Ram Nawal Rao; Nidhi Singla; Kamlesh Yadav
Journal:  Urol Ann       Date:  2013-04

7.  A case of a composite adrenal medullary tumor of pheochromocytoma and ganglioneuroma masquerading as acute pancreatitis.

Authors:  Eun-Kyoung Choi; Wan-Ho Kim; Keun-Yong Park
Journal:  Korean J Intern Med       Date:  2006-06       Impact factor: 2.884

8.  Metanephrine and normetanephrine associated with subclinical myocardial injuries in pheochromocytoma and paraganglioma.

Authors:  Yang Yu; Chuyun Chen; Wencong Han; Yan Zhang; Zheng Zhang; Ying Yang
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

9.  Pheochromocytoma presenting with myocardial infarction, cardiomyopathy, renal failure, pulmonary hemorrhage, and cyclic hypotension: case report and review of unusual presentations of pheochromocytoma.

Authors:  Meyeon Park; Katarzyna Hryniewicz; John F Setaro
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-02       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.